Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony
ORCID: 0000-0001-8547-1730, Shaw, Victoria E
ORCID: 0000-0002-0429-0186, Wadsley, Jonathan, Valle, Juan W et al (show 14 more authors)
(2017)
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
The Lancet Oncology, 18 (4).
486 - 499.
![]() |
Text
C:\Data\Papers\VIP\ViP Manuscript.docx - Submitted Version Download (158kB) |
Item Type: | Article |
---|---|
Depositing User: | Symplectic Admin |
Date Deposited: | 22 Sep 2017 08:14 |
Last Modified: | 13 Jan 2021 08:17 |
DOI: | 10.1016/S1470-2045(17)30084-0 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3009559 |
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)